All sponsors

Bristol-Myers Squibb $BMY

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS89
PHASE 3 / 2-358
RECRUITING48
READOUTS ≤12 MONTHS13
READOUT SLIPPED >6 MO34%

Delay Index: of 73 active trials registered more than a year ago, 25 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Bristol-Myers Squibb on the live radar map → 📅 $BMY readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
RELATIVITY-047
NCT03470922
P2/3Active, not recruitingMelanoma7142021-01-25 (+6 mo)
CheckMate76K
NCT04099251
P3Active, not recruitingMelanoma7902022-06-28 (-18 mo)
Abatacept
NCT04909801
P3Active, not recruitingRheumatoid Arthritis3382023-06-14 (-23 mo)
Nivolumab
NCT04025879
P3Active, not recruitingCarcinoma, Non-Small-Cell Lung4612023-07-26 (+2 mo)
Deucravacitinib
NCT04857034
P2Active, not recruitingLupus Erythematosus, Discoid; Lupus Erythematosus, Subacute Cutaneous742024-08-22 (+2 mo)
CheckMate 8HW
NCT04008030
P3Active, not recruitingMetastatic Colorectal Cancer8392024-08-28 (-2 mo)
Deucravacitinib
NCT04908202
P3Active, not recruitingPsoriatic Arthritis6702024-10-10 (+12 mo)
Deucravacitinib
NCT04908189
P3Active, not recruitingPsoriatic Arthritis7292024-11-07 (+13 mo)
Oral Azacitidine
NCT05197426
P2Active, not recruitingAcute Myeloid Leukemia192025-01-27 (+7 mo)
relatlimab+nivolumab
NCT06101134
P2Active, not recruitingMelanoma1002025-04-10 (-5 mo)
CheckMate-67T
NCT04810078
P3Active, not recruitingClear Cell Renal Cell Carcinoma6812025-07-29 (+20 mo)
Luspatercept
NCT05567458
P2Active, not recruitingBeta-thalassemia942025-08-01 (+6 mo)
RELATIVITY-127
NCT05625399
P3Active, not recruitingMelanoma5792025-08-04 (+5 mo)
MAXILUS
NCT06045689
P3Active, not recruitingMyelodysplastic Syndromes1062025-10-01 (-3 mo)
CC-486
NCT05413018
P2Active, not recruitingLeukemia, Myeloid, Acute342025-10-31 (+11 mo)
Mavacamten
NCT06253221
P3Active, not recruitingCardiomyopathy, Hypertrophic442025-11-25 (-27 mo)
CheckMate 9DX
NCT03383458
P3Active, not recruitingHepatocellular Carcinoma; Liver Cancer5452026-05-27 (+51 mo)
BMS-986369
NCT06035497
P1/2Active, not recruitingRelapsed or Refractory T-cell Lymphomas832026-08-11 (-5 mo)
BMS-986490
NCT06730750
P1/2Active, not recruitingAdvanced Solid Tumors3602026-09-05
SUCCESSOR-2
NCT05552976
P3Active, not recruitingRelapsed or Refractory Multiple Myeloma6062026-09-28 (+8 mo)
BMS-986449
NCT05888831
P1/2Active, not recruitingAdvanced Solid Tumors1002026-09-30 (+16 mo)
BMS-986278
NCT06003426
P3Active, not recruitingIdiopathic Pulmonary Fibrosis12552026-10-06
CC-92480
NCT05372354
P1/2RecruitingMultiple Myeloma2602026-10-12 (+18 mo)
POETYK SLE-1
NCT05617677
P3Active, not recruitingSystemic Lupus Erythematosus5162026-10-19 (+10 mo)
POETYK SLE-2
NCT05620407
P3Active, not recruitingSystemic Lupus Erythematosus5132026-10-19 (+10 mo)
BALSAM-1
NCT06951698
P3RecruitingBipolar-I Disorder With Mania or Mania With Mixed Features2742026-11-01
KarXT
NCT06951711
P3RecruitingBipolar Disorder Type I With Mania or Mania With Mixed Features2742026-11-02
POETYK SjS-1
NCT05946941
P3Active, not recruitingSjögren's Syndrome7742026-11-18
AURORA-HFpEF
NCT06122779
P2Active, not recruitingHeart Failure2272026-12-14 (+23 mo)
TargetTau-1
NCT06268886
P2Active, not recruitingAlzheimer Disease, Early Onset3102026-12-17 (-3 mo)
BMS-986470
NCT06481306
P1/2RecruitingAnemia, Sickle Cell; Healthy Volunteers2242027-01-06
CheckMate-1533
NCT06946797
P2Active, not recruitingNon-Small Cell Lung Cancer762027-02-05
Repotrectinib
NCT06140836
P3Active, not recruitingCarcinoma, Non-Small-Cell Lung1902027-02-16 (-24 mo)
Nivolumab
NCT03873402
P3Active, not recruitingRenal Cell Carcinoma4372027-03-11 (+50 mo)
Xanomeline/Trospium Chloride
NCT07140913
P3RecruitingMania; Bipolar Disorder4242027-06-28
Luspatercept
NCT05664737
P2Active, not recruitingAnemia1892027-07-16 (+20 mo)
BMS-986489 (Atigotatug+Nivolumab)
NCT06646276
P3RecruitingExtensive-Stage Small Cell Lung Cancer5302027-08-17 (-8 mo)
BMS-986458
NCT06090539
P1/2RecruitingRelapsed/Refractory Non-Hodgkin Lymphoma4602027-10-28
BMS-986278
NCT06025578
P3Active, not recruitingProgressive Pulmonary Fibrosis10572027-12-27
KarXT
NCT06947941
P3RecruitingAlzheimer Disease; Psychosis3252028-02-21 (+5 mo)
Iza-bren
NCT06926868
P2/3RecruitingBreast Neoplasms6002028-03-13
Pumitamig
NCT07871214
P2Not yet recruitingEarly-Stage Non-Small Cell Lung Cancer802028-03-15
ELEMENT-MDS
NCT05949684
P3Active, not recruitingMyelodysplastic Syndromes4022028-03-24 (+9 mo)
KarXT
NCT06929273
P3RecruitingBipolar Disorder Type I With Mania4502028-06-13
Oral Azacitidine
NCT05469737
P2/3Active, not recruitingMyelodysplastic Syndromes2302028-07-31 (+31 mo)
BMS-986517
NCT07160725
P1/2RecruitingSolid Tumours5402028-07-31
Navlimetostat
NCT07492680
P2RecruitingSolid Tumors2542028-08-15
BMS-986158
NCT04817007
P1/2Active, not recruitingMyelofibrosis2162028-08-31 (+58 mo)
MINDSET 1
NCT06976216
P3RecruitingAlzheimer's Disease5862028-09-11
MINDSET 2
NCT06976203
P3RecruitingAlzheimer's Disease5862028-09-11
Pumitamig
NCT07680764
P2RecruitingLocally Advanced Non-Small Cell Lung Cancer (NSCLC); Metastatic Non-Small Cell Lung Cancer (NSCLC)1602028-09-15
KarXT
NCT06882785
P3RecruitingSchizophrenia2502028-09-23
BMS-986523
NCT07223047
P1/2RecruitingAdvanced Solid Malignancies; Non-small Cell Lung Cancer (NSCLC)2522028-10-13
Xanomeline/Trospium Chloride Capsule
NCT07011745
P3RecruitingAlzheimer's Disease4262028-11-03
BMS-986511
NCT07772531
P2Not yet recruitingMajor Depressive Disorder2002028-11-06
Xanomeline/Trospium Chloride Capsule
NCT07011732
P3RecruitingAlzheimer Disease4262028-11-24
Iza-bren
NCT07100080
P2/3RecruitingNon-Small Cell Lung Cancer6612028-12-15 (+3 mo)
BMS-986504
NCT06855771
P2RecruitingCarcinoma, Non-Small-Cell Lung1822028-12-29
Deucravacitinib
NCT04772079
P3RecruitingPlaque Psoriasis1532029-01-01 (+57 mo)
BMS-986482
NCT06697197
P1/2RecruitingAdvanced Solid Tumors2862029-01-04
Iza-bren
NCT07106762
P2/3RecruitingUrothelial Cancer4702029-01-26
Iberdomide
NCT05827016
P3Active, not recruitingMultiple Myeloma12302029-03-15
BMS-986525
NCT07325136
P1/2RecruitingRelapsed/Refractory Small Cell Lung Cancer2402029-04-23
Navlimetostat
NCT07076121
P2/3Active, not recruitingPancreatic Ductal Adenocarcinoma4702029-05-03
KarXT
NCT06937229
P3RecruitingAlzheimer Disease; Agitation6502029-06-22 (+7 mo)
KarXT
NCT07284745
P3RecruitingIrritability Associated With Autism Spectrum Disorder1762029-08-06
KarXT
NCT07285798
P3RecruitingIrritability Associated With Autism Spectrum Disorder1762029-08-06
Nivolumab
NCT03899155
P2RecruitingCancer15002029-08-25 (+111 mo)
POETYK-PsO-Ped
NCT06979453
P3RecruitingPlaque Psoriasis3662029-10-12
Pumitamig
NCT07291076
P1/2RecruitingHepatocellular Carcinoma (HCC)1982029-10-15
BMS-986528
NCT07412704
P1/2RecruitingArthritis, Rheumatoid842029-10-30
BMS-986278
NCT07441408
P3Not yet recruitingPulmonary Fibrosis23802029-11-22
Pumitamig
NCT07293351
P1/2RecruitingAdvanced Renal Cell Carcinoma (RCC)4742029-11-28
KarXT
NCT07288567
P3RecruitingSchizophrenia1662029-12-18
Pumitamig
NCT07221357
P2/3RecruitingUntreated, Unresectable, or Metastatic Colorectal Cancer9902030-02-02
Deucravacitinib
NCT06869551
P3RecruitingJuvenile Psoriatic Arthritis602030-03-06
RELATIVITY1093
NCT06561386
P3RecruitingNon-small Cell Lung Cancer10002030-07-30
Pumitamig
NCT07361497
P3RecruitingNon-small Cell Lung Cancer (NSCLC)8502030-09-18
Deucravacitinib
NCT07791199
P3Not yet recruitingSystemic Lupus Erythematosus; Sjögren's Disease23002030-10-31
Pumitamig
NCT07221149
P2/3RecruitingUntreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma6902030-11-08
Deucravacitinib
NCT07116967
P3RecruitingPlaque Psoriasis30402031-01-16
BMS-986507
NCT06618287
P1/2RecruitingLung Cancer; Breast Cancer4162031-02-26 (+51 mo)
Ozanimod
NCT06408259
P3RecruitingMultiple Sclerosis, Relapsing-Remitting1942031-04-11
MountainTAP-29
NCT07063745
P2/3RecruitingMetastatic Non-small Cell Lung Cancer With MTAP Deletion5902031-08-12
BMS-986340
NCT04895709
P1/2RecruitingCervical Cancer; Gastric/Gastroesophageal Junction Adenocarcinoma11092031-08-31 (+89 mo)
Pumitamig
NCT07361510
P3RecruitingNon-Small Cell Lung Cancer (NSCLC)7502031-10-14
Iza-bren
NCT07680790
P3RecruitingNon-Small Cell Lung Cancer8502031-12-30
Ozanimod
NCT05076175
P2/3RecruitingColitis, Ulcerative1202032-07-12 (+81 mo)
Belatacept
NCT04877288
P3RecruitingRenal Allograft Recipients1022032-12-30 (+77 mo)